Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 |  STARTUP | Avg patent value: 1.50 M | ||
2 |  UNICORN | Avg patent value: 1.14 M | ||
3 |  STARTUP | Avg patent value: 100,000 | ||
4 |  STARTUP | Avg patent value: 39,200 | ||
5 |  STARTUP | Avg patent value: 15,000 |
Top 5 Startups & Unicorns companies in Monoclonal antibody
by Highest Patent Value in the South Korea in 2022
The Monoclonal antibody top 5 is Discovery PatSnap’ annual ranking of the top 5 Highest Patent Value Monoclonal antibody Startups & Unicorns in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.
Page generation time:
Jul 18 2025